| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 12/16/2004 | US20040253670 Using eschericia as bioreator for production of pasturella galactosyltransferase for use in processing sugars for use as components of pharmeceuticals |
| 12/16/2004 | US20040253665 Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them |
| 12/16/2004 | US20040253663 Genes encoding carotenoid compounds |
| 12/16/2004 | US20040253631 Expression vector comprising topisomerase site-specific recombination sequences for use as gene transfer and propagation tools in bioreactors; gene therapy; protein and gene expression analysis |
| 12/16/2004 | US20040253629 Expression vector comprising nucleotide sequences coding bcl-2-related ovarian killer (BOK) for use as diagnostic/investigative tool in elucidating mechanisms of apoptopsis, specifically in reproduction; antiproliferative agents |
| 12/16/2004 | US20040253623 Nucleic acid binding proteins |
| 12/16/2004 | US20040253621 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253599 Novel protein, its dna and use thereof |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253591 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253590 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253589 Compositions and methods for making mutations in cell lines and animals |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 12/16/2004 | US20040253268 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253267 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253266 Biological compositions and methods for treatment of esophageal cancer |
| 12/16/2004 | US20040253265 Biological compositions and methods for treatment of bladder cancer |
| 12/16/2004 | US20040253264 Biological compositions and methods for treatment of brain cancer |
| 12/16/2004 | US20040253263 Metabolically activating a culture of yeast cells by electromagnetic radiation, each defined by one of five frequency ranges and a broad range of field strength; conditioning in plant extracts and the gastric juice of animals; oral administration |
| 12/16/2004 | US20040253262 Biological compositions and methods for treatment of lymphoma |
| 12/16/2004 | US20040253261 Biological compositions and methods for treatment of pancreatic cancer |
| 12/16/2004 | US20040253260 Biological compositions and methods for treatment of cervical cancer |
| 12/16/2004 | US20040253259 Biological compositions and methods for treatment of kidney cancer |
| 12/16/2004 | US20040253258 Biological compositions and methods for treatment of testicular cancer |
| 12/16/2004 | US20040253257 Biological compositions and methods for treatment of liver cancer |
| 12/16/2004 | US20040253256 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253255 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253254 oral compositions comprising activated and conditioned yeast cells; process includes culturing yeast cells in electromagnetic fields |
| 12/16/2004 | US20040253253 Biological compositions and methods for treatment of stomach cancer |
| 12/16/2004 | US20040253252 Biological compositions and methods for treatment of leukemia |
| 12/16/2004 | US20040253251 Biological compositions and methods for treatment of ovarian cancer |
| 12/16/2004 | US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy |
| 12/16/2004 | US20040253234 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer |
| 12/16/2004 | US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253222 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 12/16/2004 | US20040253221 Novel pla1 |
| 12/16/2004 | US20040253217 Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 12/16/2004 | US20040251197 Adding at least one cell signalling chemical (CSC) such as a bacterial pheromone, a eulcaryotic hormone or a diffusible communication molecule to a sewage substrate, wherein the CSC regulates activity in at least one microbial population in the sewage substrate |
| 12/16/2004 | CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene |
| 12/16/2004 | CA2526789A1 Cells used as carriers for bacteria |
| 12/16/2004 | CA2526365A1 Methods and compositions for amino acid production |
| 12/15/2004 | EP1486571A1 Method for the recombinant production of polypeptides |
| 12/15/2004 | EP1486570A1 Method for producing L-amino acid |
| 12/15/2004 | EP1486568A1 Streptomyces sp. CJPV 975652 capable of converting compactin to pravastatin and method for producing pravastin using the same |
| 12/15/2004 | EP1486566A1 Proteins capable of binding to female sex hormones and process for producing the same |
| 12/15/2004 | EP1486505A1 Angiotensin derivatives |
| 12/15/2004 | EP1485498A2 Synthesis of synthons for the manufacture of bioactive compounds |
| 12/15/2004 | EP1485494A1 Metabolic engineering for improved xylose utilisation of saccharomyces cerevisiae |
| 12/15/2004 | EP1485491A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 12/15/2004 | EP1485486A2 Optimizing glycan processing in plants |
| 12/15/2004 | EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485475A1 Hybrid and single chain meganucleases and use thereof |
| 12/15/2004 | EP1485471A1 Alcohol dehydrogenases with high solvent and temperature stability |
| 12/15/2004 | EP1485467A2 Recombinant expression vectors for functional na sb v /sb 1.9 sodium channels |
| 12/15/2004 | EP1485463A2 Lactobacillus strains |
| 12/15/2004 | EP1485462A2 Secondary metabolite congener distribution modulation |
| 12/15/2004 | EP1485402A2 Selective extraction of dna from groups of cells |
| 12/15/2004 | EP1485397A2 Trans-splicing mediated imaging of gene expression |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
| 12/15/2004 | EP1307562B1 Nucleotide sequences which code for the lysr3 gene |
| 12/15/2004 | EP1068309B1 Enterotoxin-deficient bacillus |
| 12/15/2004 | EP1025211B1 Hyaluronan synthase gene and uses thereof |
| 12/15/2004 | EP1019488B1 Feed product |
| 12/15/2004 | EP0977866B1 Fatty acid modifying enzymes from developing seeds of vernonia galamenensis |
| 12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/15/2004 | EP0929691B1 Methods and compositions for identifying receptor effectors |
| 12/15/2004 | EP0863204B1 Human cyclin i and gene encoding the same |
| 12/15/2004 | EP0850310B1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 12/15/2004 | EP0723590B1 Subtilisin variants |
| 12/15/2004 | EP0666918B1 Production of gamma linolenic acid by a delta-6 desaturase |
| 12/15/2004 | CN1555418A Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives |
| 12/15/2004 | CN1555416A Nucleic acid sequences encoding enantioselective amidases |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
| 12/15/2004 | CN1555412A Aminopeptidase |
| 12/15/2004 | CN1555383A Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1554764A Recombinant mva virus, and the use thereof |
| 12/15/2004 | CN1554750A Subtilase variants and compositions |
| 12/15/2004 | CN1554747A Engineering strain for moducing lipopeptide and its construction method |
| 12/15/2004 | CN1554745A Pre treatment process for stabilizing beneficial microbe |
| 12/15/2004 | CN1554744A Bacillus subtilis strain |
| 12/15/2004 | CN1554743A Thuringinensin bacillus solid pelletizing and cultivating method |
| 12/15/2004 | CN1554742A Trichoderma harziarum strain |
| 12/15/2004 | CN1554741A Stabilizing post-processing method for beneficial microbial preparation |
| 12/15/2004 | CN1554740A Gas phase cultivating method for industrial wastegas purifying strain |
| 12/15/2004 | CN1554664A Compounds and methods for diagnosis of tuberculosis |
| 12/15/2004 | CN1180083C Cytochrome C and its gene |
| 12/15/2004 | CN1180082C Production method of novel mutant N-acetylglutamate synthetase and L-arginine |
| 12/15/2004 | CN1180081C A non reduction sugar forming enzyme and method for preparing sugar by these enzymes |
| 12/15/2004 | CN1180078C Microbe for degrading tobacco nicotine, and method for separating and culturing same and use thereof |
| 12/15/2004 | CN1179924C Biological phosphate fertilzier with chemical nutrient conent more than 10% and its prepn |
| 12/15/2004 | CN1179923C Method for preparing ecological fertilizer by using steam-puffed plant straw and stalk as raw material through solid fermentation |
| 12/15/2004 | CN1179622C Substratum formula of cultigen for Agrarisis blazei Murril and producing method |
| 12/14/2004 | US6831207 For incorporating into porphyrin during chlorophyll biosynthesis; qualitative/quantitative analysis |
| 12/14/2004 | US6831168 Aldehyde oxidase gene derived from plant and utilization thereof |